Lymphoma Trial, Recruiting NCT07188077 Sponsor: Ting YANG Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07188077
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People in the case group must have a confirmed diagnosis of primary central nervous system lymphoma (a type of cancer affecting the brain or spinal cord) and must not have had any cancer treatment before the initial sample is taken
  • People who are willing to sign a consent form, take part in the study, and provide samples and health information as required by the trial
  • People in the case group must have complete scan and tissue test records available (confirm with trial site)

Who may not be able to join:

  • People who have another type of cancer elsewhere in the body
  • People who have a serious infection or a severe problem with the way their body processes nutrients or chemicals
  • People who have taken certain anti-cancer or chemotherapy medicines within one week before the sample collection
  • People who are pregnant or currently breastfeeding
  • People who have a serious ongoing illness such as advanced kidney failure, heart failure, or liver failure
  • People whose ability to complete the study requirements is affected by a mental health condition or cognitive impairment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618159117171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ting YANG
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Metabolomics; CYTOF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov